The association of C-reactive protein with an oxidative metabolite of LDL and its implication in atherosclerosis

C-reactive protein (CRP) is one of the strongest independent predictors of cardiovascular disease. We have previously reported that oxidized LDL (oxLDL) interacts with β2-glycoprotein I (β2GPI), implicating oxLDL/β2GPI complexes as putative autoantigens in autoimmune-mediated atherosclerotic vascula...

Full description

Bibliographic Details
Main Authors: Masako Tabuchi, Katsumi Inoue, Hitomi Usui-Kataoka, Kazuko Kobayashi, Misako Teramoto, Koji Takasugi, Kenichi Shikata, Masahiro Yamamura, Kenji Ando, Keiichiro Nishida, Junko Kasahara, Noriaki Kume, Luis R. Lopez, Kazuaki Mitsudo, Masakiyo Nobuyoshi, Tatsuji Yasuda, Toru Kita, Hirofumi Makino, Eiji Matsuura
Format: Article
Language:English
Published: Elsevier 2007-04-01
Series:Journal of Lipid Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227520434303
id doaj-d924040b5d074996b1803f8ab213dcc3
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Masako Tabuchi
Katsumi Inoue
Hitomi Usui-Kataoka
Kazuko Kobayashi
Misako Teramoto
Koji Takasugi
Kenichi Shikata
Masahiro Yamamura
Kenji Ando
Keiichiro Nishida
Junko Kasahara
Noriaki Kume
Luis R. Lopez
Kazuaki Mitsudo
Masakiyo Nobuyoshi
Tatsuji Yasuda
Toru Kita
Hirofumi Makino
Eiji Matsuura
spellingShingle Masako Tabuchi
Katsumi Inoue
Hitomi Usui-Kataoka
Kazuko Kobayashi
Misako Teramoto
Koji Takasugi
Kenichi Shikata
Masahiro Yamamura
Kenji Ando
Keiichiro Nishida
Junko Kasahara
Noriaki Kume
Luis R. Lopez
Kazuaki Mitsudo
Masakiyo Nobuyoshi
Tatsuji Yasuda
Toru Kita
Hirofumi Makino
Eiji Matsuura
The association of C-reactive protein with an oxidative metabolite of LDL and its implication in atherosclerosis
Journal of Lipid Research
β2-glycoprotein I
oxidized LDL/β2-glycoprotein I complexes
diabetes mellitus
oxidized LDL
author_facet Masako Tabuchi
Katsumi Inoue
Hitomi Usui-Kataoka
Kazuko Kobayashi
Misako Teramoto
Koji Takasugi
Kenichi Shikata
Masahiro Yamamura
Kenji Ando
Keiichiro Nishida
Junko Kasahara
Noriaki Kume
Luis R. Lopez
Kazuaki Mitsudo
Masakiyo Nobuyoshi
Tatsuji Yasuda
Toru Kita
Hirofumi Makino
Eiji Matsuura
author_sort Masako Tabuchi
title The association of C-reactive protein with an oxidative metabolite of LDL and its implication in atherosclerosis
title_short The association of C-reactive protein with an oxidative metabolite of LDL and its implication in atherosclerosis
title_full The association of C-reactive protein with an oxidative metabolite of LDL and its implication in atherosclerosis
title_fullStr The association of C-reactive protein with an oxidative metabolite of LDL and its implication in atherosclerosis
title_full_unstemmed The association of C-reactive protein with an oxidative metabolite of LDL and its implication in atherosclerosis
title_sort association of c-reactive protein with an oxidative metabolite of ldl and its implication in atherosclerosis
publisher Elsevier
series Journal of Lipid Research
issn 0022-2275
publishDate 2007-04-01
description C-reactive protein (CRP) is one of the strongest independent predictors of cardiovascular disease. We have previously reported that oxidized LDL (oxLDL) interacts with β2-glycoprotein I (β2GPI), implicating oxLDL/β2GPI complexes as putative autoantigens in autoimmune-mediated atherosclerotic vascular disease. In this study, we investigated the interaction of CRP with oxLDL/β2GPI complexes and its association with atherosclerosis in patients with diabetes mellitus (DM). CRP/oxLDL/β2GPI complexes were predominantly found in sera of DM patients with atherosclerosis. In contrast, noncomplexed CRP isoforms were present in sera of patients with acute/chronic inflammation, i.e., various pyrogenic diseases, rheumatoid arthritis (RA), and DM. Immunohistochemistry staining colocalized CRP and β2GPI together with oxLDL in carotid artery plaques but not in synovial tissue from RA patients, strongly suggesting that complex formation occurs during the development of atherosclerosis. Serum levels of CRP correlated with soluble forms of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1, and oxLDL/β2GPI complexes correlated with total cholesterol and hemoglobin A1c. Thus, the generation of CRP/oxLDL/β2GPI complexes seems to be associated with arterial inflammation, hyperglycemia, and hypercholesterolemia. CRP/oxLDL/β2GPI complexes can be distinguished from pyrogenic noncomplexed CRP isoforms and may represent a more specific and predictive marker for atherosclerosis.
topic β2-glycoprotein I
oxidized LDL/β2-glycoprotein I complexes
diabetes mellitus
oxidized LDL
url http://www.sciencedirect.com/science/article/pii/S0022227520434303
work_keys_str_mv AT masakotabuchi theassociationofcreactiveproteinwithanoxidativemetaboliteofldlanditsimplicationinatherosclerosis
AT katsumiinoue theassociationofcreactiveproteinwithanoxidativemetaboliteofldlanditsimplicationinatherosclerosis
AT hitomiusuikataoka theassociationofcreactiveproteinwithanoxidativemetaboliteofldlanditsimplicationinatherosclerosis
AT kazukokobayashi theassociationofcreactiveproteinwithanoxidativemetaboliteofldlanditsimplicationinatherosclerosis
AT misakoteramoto theassociationofcreactiveproteinwithanoxidativemetaboliteofldlanditsimplicationinatherosclerosis
AT kojitakasugi theassociationofcreactiveproteinwithanoxidativemetaboliteofldlanditsimplicationinatherosclerosis
AT kenichishikata theassociationofcreactiveproteinwithanoxidativemetaboliteofldlanditsimplicationinatherosclerosis
AT masahiroyamamura theassociationofcreactiveproteinwithanoxidativemetaboliteofldlanditsimplicationinatherosclerosis
AT kenjiando theassociationofcreactiveproteinwithanoxidativemetaboliteofldlanditsimplicationinatherosclerosis
AT keiichironishida theassociationofcreactiveproteinwithanoxidativemetaboliteofldlanditsimplicationinatherosclerosis
AT junkokasahara theassociationofcreactiveproteinwithanoxidativemetaboliteofldlanditsimplicationinatherosclerosis
AT noriakikume theassociationofcreactiveproteinwithanoxidativemetaboliteofldlanditsimplicationinatherosclerosis
AT luisrlopez theassociationofcreactiveproteinwithanoxidativemetaboliteofldlanditsimplicationinatherosclerosis
AT kazuakimitsudo theassociationofcreactiveproteinwithanoxidativemetaboliteofldlanditsimplicationinatherosclerosis
AT masakiyonobuyoshi theassociationofcreactiveproteinwithanoxidativemetaboliteofldlanditsimplicationinatherosclerosis
AT tatsujiyasuda theassociationofcreactiveproteinwithanoxidativemetaboliteofldlanditsimplicationinatherosclerosis
AT torukita theassociationofcreactiveproteinwithanoxidativemetaboliteofldlanditsimplicationinatherosclerosis
AT hirofumimakino theassociationofcreactiveproteinwithanoxidativemetaboliteofldlanditsimplicationinatherosclerosis
AT eijimatsuura theassociationofcreactiveproteinwithanoxidativemetaboliteofldlanditsimplicationinatherosclerosis
AT masakotabuchi associationofcreactiveproteinwithanoxidativemetaboliteofldlanditsimplicationinatherosclerosis
AT katsumiinoue associationofcreactiveproteinwithanoxidativemetaboliteofldlanditsimplicationinatherosclerosis
AT hitomiusuikataoka associationofcreactiveproteinwithanoxidativemetaboliteofldlanditsimplicationinatherosclerosis
AT kazukokobayashi associationofcreactiveproteinwithanoxidativemetaboliteofldlanditsimplicationinatherosclerosis
AT misakoteramoto associationofcreactiveproteinwithanoxidativemetaboliteofldlanditsimplicationinatherosclerosis
AT kojitakasugi associationofcreactiveproteinwithanoxidativemetaboliteofldlanditsimplicationinatherosclerosis
AT kenichishikata associationofcreactiveproteinwithanoxidativemetaboliteofldlanditsimplicationinatherosclerosis
AT masahiroyamamura associationofcreactiveproteinwithanoxidativemetaboliteofldlanditsimplicationinatherosclerosis
AT kenjiando associationofcreactiveproteinwithanoxidativemetaboliteofldlanditsimplicationinatherosclerosis
AT keiichironishida associationofcreactiveproteinwithanoxidativemetaboliteofldlanditsimplicationinatherosclerosis
AT junkokasahara associationofcreactiveproteinwithanoxidativemetaboliteofldlanditsimplicationinatherosclerosis
AT noriakikume associationofcreactiveproteinwithanoxidativemetaboliteofldlanditsimplicationinatherosclerosis
AT luisrlopez associationofcreactiveproteinwithanoxidativemetaboliteofldlanditsimplicationinatherosclerosis
AT kazuakimitsudo associationofcreactiveproteinwithanoxidativemetaboliteofldlanditsimplicationinatherosclerosis
AT masakiyonobuyoshi associationofcreactiveproteinwithanoxidativemetaboliteofldlanditsimplicationinatherosclerosis
AT tatsujiyasuda associationofcreactiveproteinwithanoxidativemetaboliteofldlanditsimplicationinatherosclerosis
AT torukita associationofcreactiveproteinwithanoxidativemetaboliteofldlanditsimplicationinatherosclerosis
AT hirofumimakino associationofcreactiveproteinwithanoxidativemetaboliteofldlanditsimplicationinatherosclerosis
AT eijimatsuura associationofcreactiveproteinwithanoxidativemetaboliteofldlanditsimplicationinatherosclerosis
_version_ 1721506393870041088
spelling doaj-d924040b5d074996b1803f8ab213dcc32021-04-27T04:47:38ZengElsevierJournal of Lipid Research0022-22752007-04-01484768781The association of C-reactive protein with an oxidative metabolite of LDL and its implication in atherosclerosisMasako Tabuchi0Katsumi Inoue1Hitomi Usui-Kataoka2Kazuko Kobayashi3Misako Teramoto4Koji Takasugi5Kenichi Shikata6Masahiro Yamamura7Kenji Ando8Keiichiro Nishida9Junko Kasahara10Noriaki Kume11Luis R. Lopez12Kazuaki Mitsudo13Masakiyo Nobuyoshi14Tatsuji Yasuda15Toru Kita16Hirofumi Makino17Eiji Matsuura18Department of Cell Chemistry, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama 700-8558, JapanDepartment of Pathology, Kokura Memorial Hospital, Kitakyushu 802-8555, Japan; Department of Cardiovascular Medicine, Kurashiki Central Hospital, Kurashiki 710-8602, JapanDepartment of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama 700-8558, JapanDepartment of Cell Chemistry, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama 700-8558, JapanDepartment of Pathology, Kokura Memorial Hospital, Kitakyushu 802-8555, JapanDepartment of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama 700-8558, JapanDepartment of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama 700-8558, JapanDepartment of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama 700-8558, JapanDepartment of Cardiology, Kokura Memorial Hospital, Kitakyushu 802-8555, JapanDepartment of Orthopaedic Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama 700-8558, JapanDepartment of Internal Medicine, Okayama Central Hospital, Okayama 700-0017, JapanDepartment of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto 606-8501, JapanCorgenix, Inc., Broomfield, CO 80020Department of Cardiovascular Medicine, Kurashiki Central Hospital, Kurashiki 710-8602, JapanDepartment of Cardiology, Kokura Memorial Hospital, Kitakyushu 802-8555, JapanDepartment of Cell Chemistry, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama 700-8558, JapanDepartment of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto 606-8501, JapanDepartment of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama 700-8558, JapanDepartment of Cell Chemistry, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama 700-8558, JapanC-reactive protein (CRP) is one of the strongest independent predictors of cardiovascular disease. We have previously reported that oxidized LDL (oxLDL) interacts with β2-glycoprotein I (β2GPI), implicating oxLDL/β2GPI complexes as putative autoantigens in autoimmune-mediated atherosclerotic vascular disease. In this study, we investigated the interaction of CRP with oxLDL/β2GPI complexes and its association with atherosclerosis in patients with diabetes mellitus (DM). CRP/oxLDL/β2GPI complexes were predominantly found in sera of DM patients with atherosclerosis. In contrast, noncomplexed CRP isoforms were present in sera of patients with acute/chronic inflammation, i.e., various pyrogenic diseases, rheumatoid arthritis (RA), and DM. Immunohistochemistry staining colocalized CRP and β2GPI together with oxLDL in carotid artery plaques but not in synovial tissue from RA patients, strongly suggesting that complex formation occurs during the development of atherosclerosis. Serum levels of CRP correlated with soluble forms of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1, and oxLDL/β2GPI complexes correlated with total cholesterol and hemoglobin A1c. Thus, the generation of CRP/oxLDL/β2GPI complexes seems to be associated with arterial inflammation, hyperglycemia, and hypercholesterolemia. CRP/oxLDL/β2GPI complexes can be distinguished from pyrogenic noncomplexed CRP isoforms and may represent a more specific and predictive marker for atherosclerosis.http://www.sciencedirect.com/science/article/pii/S0022227520434303β2-glycoprotein Ioxidized LDL/β2-glycoprotein I complexesdiabetes mellitusoxidized LDL